Cognitive function and depressive symptoms in major depressive disorder: a smartphone-based study of outpatients from a sleep-disorders clinic in China - Report - MDSpire
Advertisement
Cognitive function and depressive symptoms in major depressive disorder: a smartphone-based study of outpatients from a sleep-disorders clinic in China
Cognitive Impairment Predicts Antidepressant Response in Chinese MDD Outpatients
Overview
This 8-week smartphone-based study of 321 Chinese outpatients with major depressive disorder (MDD) found that subjective cognitive dysfunction closely correlates with depressive symptom severity and independently predicts poorer antidepressant response. Baseline cognitive complaints measured by PDQ-D-20 were stable predictors of treatment outcomes, supporting routine cognitive assessment in clinical practice.
Background
Major depressive disorder (MDD) is a leading cause of disability worldwide, with cognitive impairment commonly reported alongside mood symptoms. The relationship between cognitive dysfunction and depression severity remains unclear, especially in routine clinical settings in China where patients often present with sleep complaints. Subjective cognitive dysfunction, assessed via the PDQ-D-20 questionnaire, encompasses difficulties in attention, memory, and executive function, which impact daily functioning. Understanding this relationship may improve prognostication and guide treatment strategies.
Data Highlights
Measure
Baseline
Week 2
Week 4
Week 6
Week 8
PHQ-9 (Depression Severity)
≥10 (inclusion criteria)
Data collected
Data collected
Data collected
Data collected
PDQ-D-20 (Subjective Cognition)
Measured
Measured
Measured
Measured
Measured
Sample Size
321
321
321
321
233 (completed all follow-ups)
Model AUC for Predicting Response
~0.91 (fully adjusted logistic model)
Key Findings
Higher PHQ-9 scores consistently correlated with more severe PDQ-D-20 total and domain scores at all time points.
Baseline PDQ-D-20 scores predicted smaller reductions in depressive symptoms (PHQ-9) over 8 weeks.
Baseline depressive and cognitive measures showed no significant association with demographic factors such as age, sex, education, occupation, or illness duration.
The fully adjusted logistic regression model combining baseline cognition, symptom scales, and clinical/demographic variables demonstrated good discrimination (AUC ≈ 0.91) for predicting antidepressant response.
Baseline subjective cognitive dysfunction remained an independent predictor of non-response to antidepressant treatment.
Clinical Implications
Routine assessment of subjective cognitive dysfunction using tools like the PDQ-D-20 can help identify MDD patients at risk of suboptimal antidepressant response. Integrating cognitive evaluations into clinical practice may guide personalized treatment planning and early intervention strategies, particularly in outpatient settings with sleep complaints. Smartphone-based platforms offer a feasible method for longitudinal monitoring of symptoms and cognition.
Conclusion
Subjective cognitive dysfunction is closely linked to depressive symptom burden and independently predicts poorer treatment outcomes in Chinese outpatients with MDD. Incorporating cognitive assessments into routine care may enhance prognostic accuracy and inform more comprehensive management approaches.
References
Study Authors/Good Sleep 365 Platform/2024 -- Exploring the Link Between Cognitive Impairment and Depression in Major Depressive Disorder
